A Phase II Study of Delayed Local Treatment for High Risk Neuroblastoma

A Phase II Study of Delayed Local Treatment for High Risk Neuroblastoma - Delayed Local Treatment Study for High Risk Neuroblastoma

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005045

Enrollment

Registered

2011-02-07

Start date

2011-03-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Risk Neuroblastoma

Interventions

Chemotherapy, surgery and radiation in high risk neuroblastoma

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: High risk neuroblastoma patients aged between 0.5 to 18 years old

Exclusion criteria

Exclusion criteria: Active double cancer; pregnant or possibly pregnant women and those during breast feeding; patients with psychological disease or symptoms who have difficulty in receiving protocol treatment; patients with disease that may interfere with the protocol treatment

Design outcomes

Primary

Measure	Time frame
3-year progression-free survival rate	—

Secondary

Measure	Time frame
3-year overall survival rate, the incidence of adverse events, clinical response rate before surgery	—

Countries

Japan

Contacts

Public ContactHiroyuki Shichino

National center For Global Health and Medicine Division of Pediatrics

hshichino@hosp.ncgm.go.jp0332027181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026